题名 | The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial |
杂志 | Lancet Oncology (2013), 14(9), 882-892 |
链接 | http://www.sciencedirect.com/science/article/pii/S1470204513702407 |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |